AGP Executive Report
Last update: 2 hours agoWeight-loss drugs under scrutiny: A BMJ meta-analysis of 262 randomized trials found weight-loss benefits often came with more adverse effects and no clinically meaningful quality-of-life gains, with benefits not sustained after stopping—raising the need for individualized treatment. Digital health momentum in India: India’s ABDM reported 93.95 crore ABHA registrations and 105 crore linked health records, while Poshan Tracker is expanding near real-time nutrition monitoring for POSHAN Abhiyaan. Healthcare workforce & care access: South Texas Health System’s GME consortium welcomed 65 new residents, boosting training and capacity across family medicine, internal medicine, emergency medicine and surgery. Regional medtech push in APAC: A report highlights how ageing, chronic disease and workforce shortages are driving medtech innovation across Asia-Pacific, with Singapore positioning itself as an innovation and manufacturing hub. China health diplomacy & surgical capacity: Chinese expert teams supported Ebola response in Uganda and helped Burkina Faso perform its first bronchial sleeve lobectomy, a lung-sparing procedure. Supply chain risk watch: China temporarily blocked helium exports, a move that could tighten supplies for semiconductors and MRI cooling amid already strained global availability. Disaster response spotlight: India’s “Operation Amistad” in Venezuela concluded after 8,000+ medical procedures and 20+ major surgeries. Cybersecurity pressure: Healthcare cyberattacks rose sharply in early 2026, with attackers increasingly targeting providers that can open doors to many hospitals.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.